Эгоистичная митохондрия. Как сохранить здоровье и отодвинуть старость

Todd R. D., Botteron K. N. Is attention-deficit/hyperactivity disorder an energy deficiency syndrome? Biol Psychiatry. 2001 Aug 1; 50(3):151–8. doi:10.1016/S0006-3223(01)01173-8.

Volkow N. D., et al. Differences in regional brain metabolic responses between single and repeated doses of methylphenidate. Psychiatry Res. 1998 Jul 15; 83(1):29–36. doi:10.1016 /S0925-4927(98)00025-0.

West J., et al. Response inhibition, memory and attention in boys with attention-deficit/ hyperactivity disorder. Educational Psychology. 2002; 22:533–51.

Zametkin A., et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med. 1990 Nov 15; 323(20):1361–6. doi:10.1056/NEJM199011153232001.

Синдром хронической усталости, миалгический энцефаломиелит и фибромиалгия

Aaron L. A., Buchwald D. Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. Best Pract Res Clin Rheumatol. 2003 Aug;17(4):563–74. doi:10.1016/S1521-6942(03)00033-0. Baraniuk J. N., et al. A chronic fatigue syndrome — related proteome in human cerebrospinal fluid. BMC Neurol. 2005 Dec; 5:22. doi:10.1186/1471-2377-5-22.

Barnes P. R., et al. Skeletal muscle bioenergetics in the chronic fatigue syndrome. J Neurol Neurosurg Psychiatry. 1993 Jun; 56(6):679–83. doi:10.1136/jnnp.56.6.679.

Bengtsson A., Henriksson K. G. The muscle in fibromyalgia — a review of Swedish studies. J Rheumatol Suppl. 1989 Nov; 19:144–9.

Brenu E. W., et al. Immunological abnormalities as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis. J Transl Med. 2011 May 28; 9:81. doi:10.1186/1479-5876-9-81.

Brown M. M., Jason L. A. Functioning in individuals with chronic fatigue syndrome: increased impairment with co-occurring multiple chemical sensitivity and fibromyalgia. Dyn Med. 2007 Jul 30;6:9. doi:10.1186/1476-5918-6-9.

Buchwald D., Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med. 1994 Sep 26; 154(18):2049–53. doi:10.1001/archinte.1994.00420180053007. Castro-Marrero J., et al. Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia? Antioxid Redox Signal. 2013 Nov 20;19(15):1855–60. Epub Apr 22. doi:10.1089/ ars.2013.5346.

Cordero M. D., et al. Coenzyme Q(10): a novel therapeutic approach for fibromyalgia? case series with 5 patients. Mitochondrion. 2011 Jul; 11(4):623–5. doi:10.1016/j.mito.2011.03.122.

Cordero M. D., et al. Coenzyme Q10 in salivary cells correlate with blood cells in fibromyalgia: improvement in clinical and biochemical parameter after oral treatment. Clin Biochem. 2012 Apr; 45(6):509–11. doi:10.1016/j. clinbiochem.2012.02.001.

Cordero M. D., et al. Can coenzyme Q10 improve clinical and molecular parameter in fibromyalgia? Antioxid Redox Signal. 2013 Oct 20; 19(12):1356–61. Epub 2013 Mar 4. doi:10.1089/ars.2013.5260.

Cordero M. D., et al. Is inflammation a mitochondrial dysfunction-dependent event in fibromyalgia? Antioxid Redox Signal. 2013 Mar 1;18(7):800–7. doi:10.1089/ars.2012.4892.

Devanur L. D., Kerr J. R. Chronic fatigue syndrome. J Clin Virol. 2006 Nov; 37(3):139–50. doi:10.1016/j.jcv.2006.08.013.

Exley C., et al. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. Med Hypotheses. 2009 Feb; 72(2):135–9. doi:10.1016/j.mehy.2008.09.040.

Jammes Y., et al. Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. J Intern Med. 2005 Mar; 257(3): 299–310. doi:10.1111/j.1365–2796.2005.01452.x.

Kennedy G., et al. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med. 2005 Sep 1; 39(5):584–9. doi:10.1016/j.freeradbiomed.2005.04.020. Lanea R. J., et al. Heterogeneity in chronic fatigue syndrome: evidence from magnetic resonance spectroscopy of muscle. Neuromuscul Disord. 1998 May; 8(3–4):204–9. doi:10.1016/S0960 -8966(98)00021-2.

Maes M. Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms. Curr Opin Psychiatry. 2009 Jan; 22(1):75–83

Manuel-y-Keenoy B., et al. Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome. Life Sci. 2001 Mar 16; 68(17):2037–49. doi:10.1016/S0024-3205(01)01001-3.